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Abstract. Despite the spectacular achievements of molecular biology in the second
half of the twentieth century and the crucial advances it permitted in cancer research,
the fight against cancer has brought some disillusions. It is nowadays more and
more apparent that getting a global picture of the very diverse and interlinked
aspects of cancer development necessitates, in synergy with these achievements, other
perspectives and investigating tools. In this undertaking, multidisciplinary approaches
that include quantitative sciences in general and physics in particular play a crucial
role. This ‘focus on’ collection contains 19 articles representative of the diversity
and state-of-the-art of the contributions that physics can bring to the field of cancer
research.
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1. Introduction
After the discovery of DNA as a the molecule bearing the genetic code and its double-
helix structure by Watson and Crick in 1953 [1], scientific tools and approaches towards
an understanding of the mechanisms at play in living systems started to focus more and
more on the molecular level. With the subsequent rise of biochemistry and molecular
biology in the 1950s and 1960s, spectacular progress and success were acquired, from
identifying individual gene functions and their regulations to understanding complex
molecular cascades. The field of cancer research was no exception to this rule. In
1971, President Nixon launched his National Cancer Act, which seeded the molecular
research on cancer and the hopes of finding the reductionist principles underlying its
tremendous complexity and multiple facets. It was partly fuelled by the publication the
year before of a major discovery by two independent groups, namely that of the presence
of the reverse transcriptase enzyme in viruses known to trigger tumour formation [2, 3].
Nixon’s War on Cancer, as it came to be called, aimed at identifying the retroviruses
thought to underline human cancer. But by the mid-1970s, disillusion came about,
as in most cases no human-causing retrovirus could be identified. This marked the
beginning of the ups and downs of the modern history of cancer research [4, 5]. The
program nevertheless proved to bring major advances. For one, it yielded the discovery
of oncogenes and proto-oncogenes, the genes that have the potential to drive malignant
cell proliferation either when overexpressed, mutated, or hijacked by retroviruses [6, 7].
In the subsequent years however, the complexity of the cancer disease at the
molecular scale and the impossibility to reduce it to a handful of well-identified
molecular events became more and more apparent. First, it was established that
cancer development was a multistep process, involving a succession of rate-limiting
transformations rather than a single genetic event such as a single-point mutation [8].
Then, in the 1980s and 1990s, the number of identified oncogenes and tumour suppressor
genes exploded, and the routes that cancer development could undergo proved to vary
depending on the tumour, even from the same organ and even of a given type [9, 10].
These observations underlined the necessity for larger-scale unifying principles to provide
a conceptual framework to the myriad of different faces that cancer exhibited. This led
to the proposition in the year 2000 of six ‘classical’ hallmarks of cancer, as common
biological traits of all human tumours [11]: self-sufficiency in growth signals, insensitivity
to growth-inhibitory signals, evasion of programmed cell death, limitless replicative
potential, sustained angiogenesis, and tissue invasion. Two crucial aspects of cancer
development were recognized to go along with these hallmarks, namely, genetic diversity
and instability for their speed of acquisition and the process of inflammation to support
or even promote their function. Along these lines, two years later, some generic principles
were also emphasized to underline the processes of invasion and metastases [12].
But the complexity reappeared again. It indeed soon became apparent that cancer
was not only a disease of the cell that can be handled with the tools of molecular
biology, but that it had to be addressed globally as a disease of the tumour within its so-
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called ‘microenvironment’, the environment of apparently normal cells that are recruited
during tumourigenesis and which support and potentially promote the cancer hallmarks.
Driven by this emerging understanding, 11 years after the publication of the first six
hallmarks, the publication of a seventh and a eighth hallmarks—namely, reprogramming
of energy metabolism and evading immune destruction—was accompanied by an
emphasis of the role of the microenvironment and of its complexity [13]. Among others,
the following important cell types were recognized to participate in tumour development
and cancer progression: cancer cells and cancer stem cells, endothelial cells, pericytes,
immune inflammatory cells, cancer-associated fibroblasts, and stem and progenitor cells
of the tumour stroma.
Because of this complexity, the initial hope put in Nixon’s War on Cancer has
been harshly disillusioned. Since the 1950s, age-adjusted cancer mortality rates have
declined by only 11% [14], and the prognosis for someone with metastatic cancer is as
grim today as it was some 50 years ago. In 2008, Newsweek ran a story titled “We
Fought Cancer... And Cancer Won”. Facing this reality, scientists from quantitative
disciplines such as physicists, mathematicians, computer scientists, and engineers have
contributed to cancer research over the years in different ways [14]. For one obvious
contribution, knowledge in physics and further technological developments by engineers
have permitted the use of advanced technology in medical imaging and radiation therapy
for the diagnosis and treatment of inner tumours. A second contribution is that of
bio-informatics in data mining and systems biology, which developed techniques to
handle large data sets of genome sequences, gene expression patterns, or metabolic
and cell-signalling networks, in their quest for an understanding of the emergent
properties of complex biological systems from their multi-agent molecular principles.
More recently, a third direction has shown expanding developments, namely, that of
seeking a more quantitative understanding of the physical processes involved in the
formation of a tumour in its specific microenvironment. Recently, an interagency
agreement was created to conduct an international study titled Assessment of PHysical
sciences and Engineering advances in LIfe sciences and ONcology (APHELION)
(http://wtec.org/aphelion/), led by the National Science Foundation and the National
Cancer Institute Office of Physical Sciences Oncology. The APHELION is aimed
at determining the status and trends of research and development, whereby physical
sciences and engineering principles are being applied to life sciences, cancer research,
and oncology in leading laboratories and organizations in Europe and Asia.
In the present review summarizing the ‘Focus on the Physics of Cancer’ published
by the New Journal of Physics over the past three to four years, we shall see different
aspects of the contributions and advances that physics can bring to the field of cancer
research. The selected pieces of research demonstrate the vast domain of questions and
problems that are nowadays addressed by physicists in the field, spanning different scales
and tackled with different perspectives, methods, and techniques. Addressed problems
include understanding the mechanisms of motility and force production by single cancer
cells, the influence of external mechanical constraints on their behaviour (isolated or
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within a tumour), the importance of the mechanical properties of the tumouric tissue
itself, the importance of the spatial structure of the tissue in which the tumour develops
as well as of the structures that it creates, the collective migration and the mechanisms of
invasion by cancer cells, the evaluation of the efficacy of treatments, and the development
of new diagnostic tools. They range from the molecular scale for understanding the
mechanisms of force production, motility or response to mechanical perturbations at the
single-cell level to multi-cellular or tissue scales when the development of a whole tumour
or the influence of its microenvironment are studied. Perspectives and investigating
techniques include attempts to study and quantify directly the biological reality by
developing either detailed multi-scale models or quantitative experimental techniques
for intact in vivo systems, or, on the contrary, attempts to study a simplified version of
the biological reality to extract the essence of a particular question or phenomenon by
developing analytical models of idealized situations or studying reconstituted in vitro
experimental systems.
The current collection gathers 19 articles from leading researchers in the field that
span the diverse problems, perspectives, and techniques mentioned above. Below,
we summarize the main findings of these contributions, grouping them by broad
scientific themes. The classification proposed here is somewhat arbitrary, as many
bridges, links, and complementary perspectives could have been underlined between
these contributions.
2. Spatial structure
A first group of contributions to the current focus issue can be identified under the theme
of the importance of spatial structure in the development and progression of cancer.
These contributions address the role of the spatial organization of the tissue in which
a potential tumour develops, the formation of new spatial structures by a population
of abnormal cells, as well as the dynamical evolution of a pre-existing structure such as
the interface between a proliferative epithelium and its adjacent connective tissue.
Martens et al [15] investigate the influence of the spatial tissue structure in
which mutations arise on the dynamics of cancer spread. The standard picture of
the acquisition of cancer traits is that mutations that give rise to a proliferative
advantage are acquired sequentially over time, leading to a monoclonal population of
cells. However, when the pool of pre-cancerous cells is sufficiently spread in space,
mutations occur at different locations before a given clone has had the time to spread
over the whole population. Therefore, clonal adaptation populations interfere with each
other, and the spatial organization of the original cell population influence crucially the
global outcome of evolution. The authors apply their model to the case of the human
colon, where clonal expansion could be driven by the phenomenon of crypt bifurcation,
that is the division of a given crypt into two. Advantageous mutations then spread in
the form of waves, as first described by Fisher [16], and as has been already recognized
to play a potential role for tissues in the context of tumour growth [17]. Because these
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waves spread with a constant speed, the size of clones grows linearly with time, which
is much slower than the characteristic exponential growth observed in well-mixed cell
populations. As a consequence, the fixation time of an advantageous mutation is larger,
and the waiting time for cancer is increased.
Chatelain et al [18] investigate the importance of spatial structures from another
perspective, namely, that of the structures created by the proliferating cancer cells
in an originally homogenous environment. They propose that some characteristic
morphological microstructures of skin-cancer lesions such as dots and nests may originate
from a phase-separation process between different cell populations. They draw an
analogy between the biophysics of tissues and other known phase-separation phenomena
such as those observed in block copolymers or in reaction-controlled separating mixtures.
Here, segregation occurs when adhesion between cells of the same type becomes
large enough, which may correspond to a change in cadherin expressions as observed
clinically [19]. Microstructures are found to grow in time but eventually saturate due
to the control of proliferation by the local nutrient concentration, which leads to the
formation of circular patterns. By contrast, asymmetric clusters are observed during the
transitory growth regime and resemble those found during early melanoma development.
Therefore, the presence of irregular microstructural patterns indicates that the lesion is
evolving.
Another example of both the importance of pre-existing spatial structures and the
formation of new ones due to cell proliferation is that proposed by Risler and Basan [20],
who generalize a previous study on the stability of an interface between a proliferative
epithelium and its underlying connective tissue [21]. In the epithelium, an oriented
flow of cells exists from the basal to the apical side. The originally flat basal interface
may become unstable at finite wavelength due to viscous shear stresses caused by the
position-dependent flow of cell turnover in the epithelium, which in turn may trigger the
formation of fingering protrusions into the connective tissue. An overall increase of cell
divisions in the epithelium, which corresponds to higher grades of tumour development,
tends to favour this instability. Similarly to the study by Chatelain et al above, a
parallel is drawn with another domain of physics. Here, when the cell-division rate in
the epithelium is controlled by the diffusion of nutrients coming from the underlying
vascularized tissue, a second wavelength may become unstable, corresponding to a
mechanism similar to that of the Mullins-Sekerka instability in the context of diffusion-
limited aggregation processes [22, 23].
3. Mechanical influence of the microenvironment and of geometrical
confinement on tumour growth and on the development of invasive
protrusions
Another theme present in this collection of papers is that of the importance of the
mechanical properties of either the tumour mass or its microenvironment on tumour
development. Along these lines and following a previous study [24], Montel et al [25]
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investigate the effect of an applied mechanical pressure on the long-term growth of
a spherical cell aggregate in vitro, where biochemistry and genetics can be easily
controlled. The stress is applied thanks to a difference of osmolarity between the exterior
and the interior of the aggregate. They observe that an increase in the applied pressure
results on average in a lower cellular proliferation in the spheroid. The applied pressure
affects almost exclusively the duplication rate but not substantially the cell-death rate,
and more the bulk of the spheroid than the region close to the surface. A comparison
with numerical simulations indicates that these observations can originate from pure
mechanical effects.
Drasdo and Hoehme [26] explore numerically the potential biomechanical influences
of cell-cycle entrance and cell migration on the growth and invasion pattern of a growing
tumour, depending on its surrounding environment. In a free environment, cells may
exert passive pushing forces coming from cellular proliferation (as is the case in the
model proposed by Risler and Basan [20]) as well as pulling forces due to the stretching
of cell-cell contacts. The authors attempt to decipher between the patterns resulting
from these two distinct mechanisms. Putting an environment of granular objects and
cells of another type to mimic the effect of embedding tissues, the authors find the
potential formation of invasive fingers, which become particularly pronounced when
friction between the cells and the substrate of the embedding tissue is increased. The
authors’ results resemble those observed experimentally for the growth dynamics of
multi-cellular spheroids in agarose gels [27].
Another study that investigates the dynamics of the growth of a whole tumour
is that proposed by Sciume` et al [28]. The authors present a multiphase model for
the growth of a tumour mass composed of extracellular matrix, tumour cells, healthy
cells and an interstitial fluid. The interstitial fluid helps the transport of nutrients,
and tumour cells can become necrotic upon exposure to low nutrient concentrations
or excessive mechanical pressure. The equations are solved by finite-element methods
in three different cases: 1) First that of a multicellular spheroid in a culture medium,
where the authors validate the model by experimental data. 2) Second that of a spheroid
within a healthy tissue and extracellular matrix, where they observe a reduced growth
rate as compared to the previous case. Tumour cells may eventually either displace the
healthy cells or infiltrate the healthy tissue, depending on the relative adhesion of the two
cell populations to the extracellular matrix. 3) Third that of a tumour cord where the
malignant cells grow around microvessels. Similarities in the mechanical importance
of pressure can be drawn with the experimental study of Montel et al [25], and the
potential patterns of tumour growth or invasion can be compared with the numerical
study of Drasdo and Hoehme [26].
4. Statistical models of collective cell migration and tumour spreading
In tumour spreading and metastases’ dissemination, collective cell migration potentially
plays a crucial role [29]. Nnetu et al [30] challenge the standard picture that collective
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cell migration relies mostly on cellular interactions such as cell-cell adhesions. Instead,
they propose that jamming and glass-like effects play an important role in keeping the
population cohesive, even in the absence of cell-cell adhesion. Using malignant and
non-malignant epithelial cell lines as well as fibroblasts in a two-dimensional migration
assay, the authors find that in the core of a propagating front and as a result of jamming,
cells move ballistically rather than randomly. As a result, when a cell escapes and
starts moving randomly, the propagating front catches up such that an effective stable
boundary is observed on long time scales. When two monolayers meet, slowed-down
dynamics and jamming effects lead to the formation of stable borders, even between
monolayers of the same cell type.
Lee et al [31] characterize the flow field of a migrating sheet of cells acquired with
particle-image velocimetry. Using a finite-time Lyapunov exponent analysis, the authors
find that the flow field is not chaotic. Stretching of the sheet is localized at the leading
edge of migration and increases with stimulation. Surprisingly, they also find that plastic
rearrangements increase with increasing cell densities, an observation that is in contrast
with inanimate systems.
Along these lines but modelling an in-vivo three-dimensional situation, Fort and
Sole´ [32] develop a model of biased random walk to investigate the cell dispersal of
gliobastomas, which are highly diffuse, malignant tumours. The authors show the
importance of the bias effect from adjusting the values of three relevant parameters of an
analytical model, without the need to perform heavy numerical simulations. Potentially,
the authors’ model could allow incorporation of the bias effect into the simulations of
glioblastoma invasion that are nowadays currently performed for individual patients [33].
This could grandly modify the predictions of such simulations and, therefore, lead to
potentially essential clinical implications.
5. Cytoskeleton and sub-cellular processes - force generation at the
single-cell level
Four contributions of the focus issue investigate the production of the mechanical
forces relevant for metastatic cell invasion and motility at the single-cell level. Cell
motility relies on a balance of biomechanical processes such as cell adhesion and de-
adhesion [34], cytoskeletal remodelling [35], protrusive force generation [34], as well as
on matrix properties such as stiffness, pore size, protein composition and enzymatic
degradation [36]. In this context, Mierke [37] investigates the role the αvβ3 integrin
in cancer-cell invasion through increased cellular stiffness and enhanced cytoskeletal
remodelling, which allow the generation and transmission of contractile forces. Using
different cancer cell lines expressing high or low levels of this integrin (respectively
αvβ3high and αvβ3low cells), she finds that αvβ3high cells have a threefold increase in
their invasion compared to αvβ3low cells. Using a myosin light chain kinase inhibitor,
she could show that contractile forces are essential for the increase in cellular stiffness
mediated by αvβ3 integrins and subsequently for the enhanced cancer-cell invasion. She
Focus on the Physics of Cancer 8
could, for example, rescue the cellular invasiveness of αvβ3low cells after addition of the
contractility enhancer calyculin A.
Kristal-Muscal et al [38] study the process of substrate indentation by metastatic
cells, corresponding to the initial stage of metastatic penetration into the adjacent tissue
and extracellular matrix. Thanks to an in vitro system, they mimic the penetration of
metastatic cells into the extracellular matrix or through the endothelial cells of a blood-
vessel wall. Their observations reveal the existence of an indentation process based
purely on the production of mechanical forces. Cells with higher metastatic potential
are softer but are found to apply stronger forces than non-metastatic cells, and benign
cells do not indent substrates at all. Cells are also found to develop forces more readily
on stiffer gels, which provide grip handles for the cells to hold on to. Therefore, substrate
stiffness and adhesion properties may be viable targets against metastatic penetration,
suggesting new potential avenues of treatment.
After indentation and penetration of the cancer cells into adjacent tissues, cancer-
cell motility—their ability to move—is thought to play an important role in the
colonization of other tissues and the formation of metastases [39, 40, 41]. Along these
lines, two papers of this series investigate the mechanisms of cell motility at the level
of the cell lamellipodium. Zimmermann and Falcke [42] model the lamellipodium
as a viscoelastic actin gel in its bulk and a dynamic boundary layer of newly
polymerized filaments at its leading edge. The authors find three different parameter
regimes: a stable, stationarily protruding lamellipodium; a stable lamellipodium
showing oscillatory motion of the leading edge; and no stable lamellipodium with zero
filament density. The authors also investigate the dynamic force-velocity relation and
predict that it should change if the cell experiences a constant force for a long time.
This is due to the fact that filament number can adjust if a force is applied for a long
time and should therefore happen independently of cell signalling [43, 44]. The authors
point out that since cells typically experience the forces exerted by surrounding tissues
over a long time, dynamic force-velocity relations as traditionally measured in vitro may
not be relevant for actual tissues.
Another study that addresses the mechanisms of cell motility and lamellipodium
mechanics is that by Havrylenko et al [45], who investigate a mechanism of cell motility
that does not rely on an acto-myosin cytoskeleton, as does cell migration in mammalian
systems. Their model system is the Caenorhabditis elegans sperm cell, which has a
cytoskeleton that is biochemically different and has no structural similarity to actin,
and for which no associated molecular motors is known [46, 47]. Studying the migration
properties of these cells in different adhesive conditions, the authors find that their
migration nevertheless displays the same molecular characteristics as that of acto-
myosin-containing cells. In particular, they find the existence of a backward (retrograde)
flow of the cytoskeleton toward the cell body, resulting from slippage of the cytoskeleton
with respect to the substrate and driven by cytoskeletal assembly and contractility.
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6. Influence of external biomechanical conditions on mechanosensing and
on mechanical regulation of cancer cells and tissues
A substantial number of papers of this series look at the importance of the biomechanical
properties of cancer cells, tumouric tissues, and their environments, as well as on the
influence of external forces on these or other properties, including cell fate. This is the
case of papers already discussed above, such as those presented in sections 3 and 5,
for example. But external biomechanical conditions can also have a direct influence at
the cell level on properties as essential as cell survival. The study by Montel et al [25]
discussed in section 3 shows such an example. Another example is that studied by
Mitchell and King [48], who investigate the influence of hydrodynamic shear forces on
the survival of circulating tumour cells. In particular, the sensitization of colon and
prostate cancer cells to apoptotic agents by fluid shear forces increases in an intensity-
and time-dependent manner. Low interstitial fluid flows such as those found in the
tumour microenvironment are not sufficient to influence the cell response but the flows
present in the blood circulation could explain why only a small portion of circulating
tumour cells survive and generate metastases [49].
Nolting and Ko¨ster [50] study another aspect of the influence of fluid shear flows,
namely, that on the networks of keratin intermediate filaments. Intermediate filaments
are part of the cytoskeleton along with microtubules, actin filaments, associated proteins,
and molecular motors [51, 52, 41]. One function of these fibrous proteins is to
withstand potentially harmful mechanical influences and to guarantee the integrity of
the cell [53, 54]. As it was previously known that the dynamics of the keratin network is
influenced when the cell is exposed to shear stresses, it was unknown which part of the
dynamics and by which mechanism the keratin network is affected. Upon application
of fluid shear flow, the authors find that bundle dynamics is reduced on a timescale
of minutes. They show evidence that the regulation is active and comes from the
acto-myosin network, which rigidifies and transmits its rigidity to the keratin network.
Therefore, the cytoskeletal cross-talk between keratin and actin networks appears to be
shear-stress dependent.
Two papers of the focus series study the influence of either the microenvironment
or the external mechanical constraints on the stiffness properties of individual cells
or entire tissues. It is indeed now established in several tumour types that individual
tumour cells have distinct biophysical and biomechanical properties as compared to their
healthy counterparts [55, 56], and that this is the case also at the tissue level (see below).
Using an Atomic Force Microscope with a 5.3 µm diameter spherical probe, Guo et
al [57] study the stiffness of individual human mammary epithelial cells in four different
phases of cancer progression, namely, studying normal (non-transformed), immortal,
tumourigenic, and metastatic cells. They determine the elastic moduli of cells in all
four phases as a function of the subregion of the cell (over the nucleus versus over
the cytoplasm) and of the cell’s microenvironment (inside, at the periphery, or isolated
outside of a contiguous cellular monolayer). The authors find that there are only minor
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to negligible differences in stiffness between cellular subregions and that cells become
globally softer as they advance to the tumourigenic phase, except in the final step to
becoming metastatic. They find that normal epithelial cells are stiffer when surrounded
by other cells within a monolayer but that the microenvironment has only a slight effect
on transformed cells, sometimes opposite.
At the tissue level, a common feature of several disease states, like fibrosis or some
types of cancers such as breast, colon or pancreatic cancers, is distinct biophysical
properties from those of the normal tissues from which they originate. For example,
diseased tissues often present an increased interstitial fluid pressure [58] and solid tissue
stress [59, 60]. They are also often stiffer [61], a fact that has been suggested to
contribute to disease progression [62]. Pogoda et al [63] study the elastic properties
of normal and tumouric brain tissues. The authors show that normal-brain and glioma
tissues increase their shear elastic moduli under modest uniaxial compression but not
under elongation or increased shear strains, the effect being more pronounced for glioma
tissue. It is suggested that compression stiffening, which might occur with the increased
vascularization and interstitial pressure gradients that are characteristic of glioma and
other solid tumours, effectively stiffens the environment. From the in vitro observations
regarding the response of glioma cells to substrate stiffness change [64, 65], the increased
local stiffness might contribute to increased tension, motility and proliferation of the
tumour cells.
7. Modelling of treatments and imaging techniques
The contribution of physics to the field of cancer research presented in this ‘focus on’
series does not end with the attempt at understanding the properties of cancer cells,
tissues and disease progression. It is also shown that physics contributes in modelling
the efficacy and principles of diagnostic techniques and of treatment delivery. Two
examples of the contribution of physics in these domains are presented in the current
series. Following on the specificities of the biomechanical properties of tumouric tissues,
Simon et al [66] investigate magnetic resonance elastography (MRE) as a tool for the
clinical diagnosis of intracranial neoplasm. MRE is a non-invasive medical imaging
technique that measures the mechanical properties of soft tissues by introducing shear
waves and imaging their propagation, thanks to magnetic resonance imaging (MRI) [67].
It is used in a variety of diseases’ diagnoses, but MRE still suffers from limited spatial
resolution due to ill-posed inverse problems required for parameter recovery [68]. In their
work, the authors improved the capability of MRE to obtain spatially resolved maps of
viscoelastic constants in the biomechanical characterization of cerebral tumours in their
natural environment. Their preliminary data reveal a loss of stiffness in malignancies
compared to healthy reference tissues or benign variants. It should be noted that this
is somewhat in contradiction with the study of Pogoda et al [63] discussed above, which
predicts a stiffening of glioma tissues due to compression. It might be that Simon
et al find the opposite because of different tumour types, disease stage or degree of
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compression. The softening of numbers of tumours may be due to a reduction in cross-
linking network capability or structure, a notion supported by biophysical single-cell
studies. Cancerous behaviour of tumour cells has indeed been attributed to cytoskeletal
transformations, which soften the cell’s response to small deformations and potentially
increases its invasive aggressiveness [55] or facilitates the tumour growth at the extent of
the neighbouring tissue [69]. When sufficiently sensitive, MRE could provide a predictive
marker for tumour malignancy and thereby contribute to an early non-invasive clinical
assessment of suspicious cerebral lesions.
The second presented contribution to improving the efficacy of cancer treatment is
that of modelling the delivery of nanotherapeutics, which aim at targeting specifically
the diseased tissue. Nanotherapeutics consists in concentrating the drugs inside
nanoscale vehicles, in order to enhance drug accumulation within tumours as compared
with conventional chemotherapeutics, which relies on pure passive diffusion. In this
series, van de Ven et al [70] develop a theoretical framework for modelling the delivery
of nanotherapeutics based on the automated evaluation of vascular perfusion curves
measured at the single-vessel level. The vascular perfusion curves contain data acquired
using video-rate laser-scanning microscopy and consisting of blood flow velocity, flux and
hematocrit measured by tracking trajectories of fluorescent red blood cells [71]. This
approach enables an automated ranking of tumour vascular perfusion in order to model
the delivery of nanotherapeutics, without requiring any underlying assumptions about
tissue structure, function, and heterogeneities. Such rankings can be correlated with
a variety of quantifiable physiological parameters in order to evaluate the behaviour
of a given tumour. The resulting rankings are found to correlate inversely with
experimental nanoparticle accumulation measurements. With additional calibration,
these methodologies may enable the investigation of nanotherapeutics delivery strategies
in a variety of tumour models.
8. Summary and outlook
The ‘Focus on the Physics of Cancer’ collection offers various examples of the state of
the art of the contribution of physical sciences to the field of cancer research. These
span different scales ranging from molecular assemblies to tissue spatial organization.
They present a large variety of different questions such as the role of biomechanics in
tumour growth and cancer-cell behaviour, the role of the microenvironment and of its
biophysical properties, the role and mechanisms of the collective migration of cancer
cells, and the cytoskeletal organization at the single-cell level and its influence on cell
mechanics and migration, as well as the exploitation of particular biophysical properties
of tissues and of the circulating system in developing new diagnostic tools and drug
delivery strategies.
The history of cancer research has been paved with ups and downs, with reductionist
hopes and periods of harsh disillusions, demonstrating the need of a wider-angle of view
than molecular biology alone would be able to offer. Cross-disciplinary collaborations
Focus on the Physics of Cancer 12
have had a long history in cancer research. They enable to grasp the mechanisms of the
cancer disease at greater spatial and temporal scales and with wider perspectives. In
this collective undertaking, physics contributes in a crucial way.
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